tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Frank Takkinen, 149 are a BUY (94.9%), 8 are a HOLD (5.1%).
Analyst Frank Takkinen, currently employed at LAKE STREET, carries an average stock price target met ratio of 46.05% that have a potential upside of 29.13% achieved within 125 days.
Frank Takkinen’s has documented 305 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on RCEL, Avita Medical Ltd at 28-Aug-2026.
Analyst best performing recommendations are on COCH (ENVOY MEDICAL).
The best stock recommendation documented was for NOTV (INOTIV) at 5/16/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.14 (6.54%) receiving and performance score of 65.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Feb-2026
$78
$9.21 (13.39%)
$62
9 days ago
(14-Oct-2026)
26/46 (56.52%)
$9.93 (14.59%)
129
Buy Since 01-Jul-2026
$97
$28.21 (41.01%)
$97
21 days ago
(02-Oct-2026)
1/3 (33.33%)
$27.03 (38.63%)
34
Buy Since 05-Mar-2026
$80
$11.21 (16.30%)
$65
1 months 12 days ago
(11-Sep-2026)
17/23 (73.91%)
$7 (9.59%)
54
Hold Since 04-Aug-2026
$60
$-8.79 (-12.78%)
$55
2 months 19 days ago
(04-Aug-2026)
27/35 (77.14%)
$-4.14 (-6.45%)
178
Buy Since 13-Apr-2023
$65
$-3.79 (-5.51%)
$55
2 months 19 days ago
(04-Aug-2026)
10/17 (58.82%)
$0.86 (1.34%)
64
Which stock is Frank Takkinen most bullish on?
What Year was the first public recommendation made by Frank Takkinen?
